The HGF/c-MET pathway also regulates epithelial–mesenchymal transition (EMT) in NSCLC, an important process that enhances tumor cell migration and invasion, and serves as an adaptive drug resistance mechanism [79]. This evidence concerns the gene MET and non-small cell lung carcinoma.